Literature DB >> 7805035

Microsatellite instability and other molecular abnormalities in non-small cell lung cancer.

K M Fong1, P V Zimmerman, P J Smith.   

Abstract

Microsatellites are highly polymorphic, short-tandem repeat sequences dispersed throughout the genome. Instability of these repeat sequences at multiple genetic loci may result from mismatch repair errors and occur in hereditary nonpolyposis colorectal carcinoma and certain sporadic cancers. In non-small cell lung cancer, we found that microsatellite instability was infrequent, affecting only 7 (6.5%) of 108 cases. Despite being observed in all histological subtypes and at different tumor stages, microsatellite instability most commonly affected only one of the six loci tested on five chromosomal arms. In addition, microsatellite instability was associated with extensive, concurrent molecular changes including K-ras and p53 mutations as well as frequent loss of heterozygosity at chromosomal regions 5q, 8p, 9p, 11p, and 17p.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7805035

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Microsatellite alteration in multiple primary lung cancer.

Authors:  Cheng Shen; Xin Wang; Long Tian; Guowei Che
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

Review 3.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

4.  Elevated microsatellite alterations at selected tetra-nucleotide (EMAST) in non-small cell lung cancers--a potential determinant of susceptibility to multiple malignancies.

Authors:  Hiromasa Arai; Koji Okudela; Hisashi Oshiro; Noriko Komitsu; Hideaki Mitsui; Teppei Nishii; Masahiro Tsuboi; Akinori Nozawa; Yasuharu Noishiki; Kenichi Ohashi; Kenji Inui; Munetaka Masuda
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

5.  Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.

Authors:  Brian Pedro; Manali Rupji; Bhakti Dwivedi; Jeanne Kowalski; Jessica M Konen; Taofeek K Owonikoko; Suresh S Ramalingam; Paula M Vertino; Adam I Marcus
Journal:  Cancer       Date:  2020-04-21       Impact factor: 6.860

6.  Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma.

Authors:  P Mendes-da-Silva; A Moreira; J Duro-da-Costa; D Matias; C Monteiro
Journal:  Mol Pathol       Date:  2000-08

7.  Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.

Authors:  K Hurr; B Kemp; S A Silver; A K el-Naggar
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

8.  Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.

Authors:  V G Gorgoulis; E N Koutroumbi; A Kotsinas; P Zacharatos; C Markopoulos; L Giannikos; V Kyriakou; Z Voulgaris; I Gogas; C Kittas
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

9.  Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Authors:  V G Gorgoulis; P Zacharatos; A Kotsinas; T Liloglou; A Kyroudi; M Veslemes; A Rassidakis; T D Halazonetis; J K Field; C Kittas
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases.

Authors:  Arne Warth; Sandrina Körner; Roland Penzel; Thomas Muley; Hendrik Dienemann; Peter Schirmacher; Magnus von Knebel-Doeberitz; Wilko Weichert; Matthias Kloor
Journal:  Virchows Arch       Date:  2015-12-04       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.